Bank Oke Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Oke Indonesia Tbk trades at Rp121 (market cap 2.07T, 533.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Bank Oke Indonesia Tbk is far larger — about 12.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Oke Indonesia Tbk is more actively traded (533.2K versus 187.4K). Which is the better fit depends on your goals.
| DNAR | OBAT | |
|---|---|---|
Market Cap | 2.07T | 164.65B |
Volume | 533.2K | 187.4K |
Lot | 5.33K | 1.87K |
Turnover | 64.79M | 44.35M |
Average Price | 121.51 | 236.67 |
Value | 64.79M | 44.35M |
Indicative Equilibrium Price | 121 | 242 |
Indicative Equilibrium Volume | 398 | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Dinar Indonesia Tbk (the Bank) formerly PT Bank Liman International was established based on Notarial Deed No. 99 dated August 15, 1990 of James Herman Rahardjo, S.H.
Read more on DNAR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →